Compare BlackBerry Limited (BB) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BlackBerry Limited vs Novartis AG — how do they compare? BlackBerry Limited trades at $9.17 (market cap $5.27B), while Novartis AG trades at $152.33 (market cap $295.37B). The key difference: Novartis AG is far larger — about 56× BlackBerry Limited's market cap, and Novartis AG pays a 3.07% dividend while BlackBerry Limited pays none. Which is the better fit depends on your goals.
| BB | NVS | |
|---|---|---|
Market Cap | $5.27B | $295.37B |
Sector | Technology | Health |
52-Week High | $12.81 | $168.62 |
52-Week Low | $3.15 | $119.31 |
Enterprise Value | $5.14B | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BlackBerry Limited
BlackBerry Limited provides intelligent security software solutions. The Company offers artificial intelligence and machine learning for cybersecurity, safety, and data privacy solutions, as well as endpoint security and management, encryption, and embedded systems. BlackBerry serves governments and enterprise sectors worldwide.
Read more on BB →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
